Literature DB >> 32602436

Feasibility of GeneXpert® Edge for Tuberculosis Diagnosis in Difficult-to-Reach Populations: Preliminary Results of a Proof-of-Concept Study.

Marcelo Cordeiro-Santos1,2,3, Jair Dos Santos Pinheiro3,4, Renata Spener-Gomes1,2, Alexandra Brito de Souza1,2, Maria Gabriela de Almeida Rodrigues1,2, Jayne Marina Pinto da Silva1, Jaquelane Silva Jesus1, Daniel Souza Sacramento4, Artemir Coelho de Brito5, Mayara Lisboa Soares de Bastos6, Allyson Guimarães Costa1,2, Anete Trajman6.   

Abstract

GeneXpert® Edge (GX-Edge) is a new point-of-care platform not yet tested in the field. In this proof-of-concept study conducted for the diagnosis of tuberculosis in communities living alongside two large rivers of the Brazilian Amazon, we demonstrate that GX-Edge implemented in boats to offer onsite testing is a feasible strategy to investigate potentially devastating diseases such as tuberculosis in difficult-to-reach populations, such as riverside communities.

Entities:  

Mesh：

Year:  2020        PMID： 32602436      PMCID： PMC7470582          DOI： 10.4269/ajtmh.20-0326

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


  1 in total

1.  Diagnostic accuracy of the new Xpert MTB/RIF Ultra for tuberculosis disease: A preliminary systematic review and meta-analysis.

Authors:  Meng Zhang; Miao Xue; Jian-Qing He
Journal:  Int J Infect Dis       Date:  2019-09-20       Impact factor: 3.623
  1 in total
  3 in total

1.  Snakebites in "Invisible Populations": A cross-sectional survey in riverine populations in the remote western Brazilian Amazon.

Authors:  Guilherme Kemeron Maciel Salazar; Joseir Saturnino Cristino; Alexandre Vilhena Silva-Neto; Altair Seabra Farias; João Arthur Alcântara; Vinícius Azevedo Machado; Felipe Murta; Vanderson Souza Sampaio; Fernando Val; André Sachett; Paulo Sérgio Bernarde; Marcus Lacerda; Fan Hui Wen; Wuelton Monteiro; Jacqueline Sachett
Journal:  PLoS Negl Trop Dis       Date:  2021-09-09

Review 2.  Diagnosing Tuberculosis: What Do New Technologies Allow Us to (Not) Do?

Authors:  Shima M Abdulgader; Anna O Okunola; Gcobisa Ndlangalavu; Byron W P Reeve; Brian W Allwood; Coenraad F N Koegelenberg; Rob M Warren; Grant Theron
Journal:  Respiration       Date:  2022-06-27       Impact factor: 3.966

Review 3.  Towards Accurate Point-of-Care Tests for Tuberculosis in Children.

Authors:  Nina Vaezipour; Nora Fritschi; Noé Brasier; Sabine Bélard; José Domínguez; Marc Tebruegge; Damien Portevin; Nicole Ritz
Journal:  Pathogens       Date:  2022-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.